KCL

What KCL does

KCL (Oy Keskuslaboratorio-Centrallaboratorium Ab) is a Finland-based open-access piloting and laboratory services provider for the bioeconomy, founded in 1916 by the Finnish forest industry and now operating under private ownership following a management buyout in January 2023. The company operates a vertically integrated platform spanning fiber processing (refining, crushing/milling, chemical treatment, extraction, filtration), dispersion and extrusion coating (including 5-layer coextrusion), sheet-fed offset and flexo printing, finishing and converting, and accredited laboratory services (recyclability, microbiology, chemical analysis, calibration). It sells access to specialized equipment as a service to forest-industry majors, brand owners pursuing sustainable packaging, bioeconomy companies, and startups such as Paptic and DELSCI that lack capital to build their own pilot facilities.

KCL complements its services portfolio with proprietary biomaterial products, including KCL Biowax (an FDA-approved MFC-stabilized natural wax dispersion for paper-based hydrophobic barriers), KCL Microfibrillated Cellulose and Cellulose Nanofibers, and the KCL Formi 3D biocomposite line for large-format 3D printing (acquired from UPM in 2024). Revenue streams combine professional services (piloting, laboratory testing), contract manufacturing (MFC, CNF, chemical modification of biomass), hardware/product sales (biocomposite materials), and licensing/royalties. Pricing is quote-based across the service lines, while the BIOHUB cluster membership is free.

The go-to-market is sales-led, with a dedicated Head of Sales and New Business Development targeting European market expansion and a stated objective to double sales within five years and source 50% of revenues from outside Finland. Distribution combines direct enterprise sales with channel partnerships such as the Nordic Pilot Center joint offering with Fiber-X Finland Oy. KCL relocated from Espoo (Otaniemi) to a rented 10,000 m2 industrial hall in Lohja during 2024-2025 and has grown headcount through senior hires across R&D, biomaterial processing, sales, and biocomposite development. The company operates as a validated CEPI-CTS lab for recyclability certification and participates in multiple industry consortia including 4evergreen, innpressme, expandfibre, and the Bio-based Industries Consortium.

Name

KCL

Legal name

Oy Keskuslaboratorio-Centrallaboratorium Ab

Website

https://kcl.fi

Company type

Private

Founded year

1916

Operating status

Operating

Headcount range

251–500 employees

Short description

KCL is a Finland-based open-access piloting and laboratory services provider for the bioeconomy, founded in 1916 by the Finnish forest industry and now privately held post-2023 management buyout. It serves forest-industry majors, brand owners, and biomaterial startups with fiber processing, coating, printing, finishing, laboratory testing, and proprietary biomaterial products.

Ownership category

akta.pro rank

Product category

Bioeconomy Piloting and Laboratory Services

NAICS

Testing Laboratories and Services (541380)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB)

Keywords

• Bioeconomy piloting services
• Biomaterial processing
• Laboratory testing services
• Fiber processing platform
• Cellulose nanofiber materials

Headquarters

HQ city

Espoo

HQ country

Finland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Piloting Services: Open access piloting services for fiber processing, coating, printing, finishing and converting. Provides demonstration of first prototypes for new products enabling market entry.
2. Laboratory Services: Laboratory scale simulations, troubleshooting, testing and analyses covering pulp refining, board & papermaking, barrier property testing, chemical analysis, recyclability testing, microbiology, and calibration services.
3. Contract Manufacturing: Contract manufacturing services for microfibrillar cellulose (MFC), cellulose nanofibers (CNF), and chemical modification of biomass. Production of biocomposite materials including Formi product line.
4. Biomaterial Products: Proprietary biomaterial products including KCL Biowax, KCL Microfibrillated Cellulose, KCL Cellulose Nanofibers, and KCL Formi 3D biocomposite materials for 3D printing and injection moulding.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

KCL provides open-access piloting services and laboratory testing for the bioeconomy, covering fiber processing, dispersion and extrusion coating, extrusion coating & lamination, printing, finishing & converting, and a full laboratory service suite. The company also sells proprietary biomaterials (KCL Biowax, MFC, CNF) and KCL Formi 3D biocomposites for large-format 3D printing, and offers contract manufacturing of microfibrillar cellulose, cellulose nanofibers and chemical modification of biomass.

Product overview

KCL (Oy Keskuslaboratorio-Centrallaboratorium Ab) is a piloting and laboratory services provider for the bioeconomy, offering over 100 years of expertise in green transition technologies. The company's portfolio centers on fiber processing and biomaterial development services, organized around core piloting platforms (fiber processing, coating, printing, finishing) complemented by specialized product lines (KCL Biomaterials, KCL Biocomposites, KCL Formi™ 3D). KCL operates through its KCL BIOHUB competence cluster and participates in the Nordic Pilot Center partnership with Fiber-X Finland Oy. Services range from laboratory-scale testing to full-scale pilot trials, with proprietary biomaterial products including KCL Biowax, MFC, CNF, and the KCL Formi™ 3D biocomposite product line acquired from UPM's biocomposites business.

Differentiator

Problem solved

Functional benefit

Brands

• KCL Biomaterials: Novel biomaterials including KCL Biowax (water-based dispersion of natural wax stabilized by microfibrillated cellulose), KCL Microfibrillated cellulose, and KCL Cellulose nanofibers for paper and board industry applications.
• KCL Biocomposites
• KCL BIOHUB
• Nordic Pilot Center

Products and services

• Fiber Processing Platform Comprehensive fiber processing services including refining, crushing/milling/mixing, chemical treatment, extraction, filtration, and finishing & support services for developing new processes and scaling up existing operations; for forest industry, brand owners, biomaterial startups and bioeconomy companies.
• Dispersion and Extrusion Coating Coating services from coating kitchen and lab-scale coating through semi-pilot and full-scale pilot coating, plus laboratory analyses, used to develop barrier products and replace plastics with bio-based alternatives.
• Extrusion Coating and Lamination Pilot-scale extrusion coating and lamination services featuring 5-layer coextrusion with encapsulation function and pre/post surface treatment options, for multi-layer barrier and packaging material development.
• Printing Sheet-fed offset and flexo printing services for customers performing surface development and material performance testing in real printing process environments.
• Finishing & Converting Finishing services providing rewinding, slitting, sheet cutting and packing of materials into formats suitable for printing, converting or laboratory analyses.
• Laboratory Services Laboratory scale simulations of individual process stages plus troubleshooting, testing and analyses covering laboratory refining of pulp, pulp treatment, board & papermaking, paper/board/packaging testing, chemical analysis, recyclability & biodegradability, print quality testing, microbiology and calibration services.
• KCL Biowax Water-based dispersion of natural wax stabilized by microfibrillated cellulose (MFC) providing hydrophobic properties for paper and board products. FDA-approved for food contact applications and classified outside the single-use plastic directive.
• KCL Microfibrillated Cellulose (MFC) Proprietary microfibrillated cellulose product used for stabilization, rheology optimization and biomaterial processing in paper and board applications.
• KCL Cellulose Nanofibers (CNF) Proprietary cellulose nanofiber product for advanced biomaterial applications in paper, board and packaging systems.
• KCL Formi 3D Nordic Birch PLA10 Bio-based PLA composite with cellulose fiber designed for large-format 3D printing, offering strong mechanical properties, excellent printability, faster printing at lower temperatures, and sustainable end-of-life options.
• KCL Formi 3D Iconic Black UV-resistant bio-based PLA composite with carbon black, designed for outdoor 3D printing applications with deep black color, excellent printability and smooth semi-matte surface finish.
• Contract Manufacturing Contract manufacturing services for microfibrillar cellulose (MFC), cellulose nanofibers (CNF), and chemical modification of biomass, enabling customers to produce first prototypes of new products.
• CEPI-CTS Recyclability Testing Service CEPI Comparative Testing Service (Level 1 and Level 2) for recyclability of paper-based packaging and 3D products, with KCL acting as a validated lab able to issue recyclability certificates according to the CEPI method.

Quantifiable outcome

• Relocation to 10,000 m2 facility representing 30% expansion
• +1 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• CEADcoreStrategic or Co-development Partner · 1 August 2025Partnership with CEAD, global leader in large format additive manufacturing (LFAM) technology, to advance sustainable 3D printing. KCL's cutting-edge biocomposite materials (KCL Formi) have been successfully tested with CEAD's hybrid 3D printing systems, confirming compatibility and opening new opportunities for bio-based circular production.
• Food Contact Center (FCC)coreStrategic or Co-development Partner · 1 January 2025Partnership bringing together extensive expertise in material safety, testing, and pilot-scale production for fiber-based food packaging innovations. FCC provides laboratory testing, risk assessment, and consulting on food contact materials while KCL offers material innovation and performance testing capabilities.
• Fiber-X Finland OycoreStrategic or Co-development Partner · 4 November 2024Combined expertise to create Nordic Pilot Center providing more comprehensive services for piloting and development of paper, board and biofibre-based materials. Covers material development, extensive industrial piloting, and process/plant design. KCL and Fiber-X continue as independent companies.
• UPMcoreTechnology or Integration · 1 January 2024Acquisition of advanced biocomposite manufacturing equipment from UPM, which withdrew from biocomposite products. Equipment enables KCL to commence production of innovative biocomposite materials including Formi products for injection moulding and 3D printing.
• 4evergreenminorStrategic or Co-development PartnerCircular economy forum for fiber-based packaging ecosystem. KCL collaborates with this industry alliance.
• innpressmeminorStrategic or Co-development PartnerEU funded project ecosystem for recyclable and/or biodegradable packaging, energy, and vehicle solutions. KCL is a partner in this innovation ecosystem for bio-based consumer products.
• expandfibreminorStrategic or Co-development PartnerIndustry collaboration focused on expanding fiber-based solutions. KCL collaborates as part of the bioeconomy ecosystem.
• Bio-based Industries ConsortiumminorStrategic or Co-development PartnerEuropean consortium for bio-based industries. KCL collaborates as part of this ecosystem supporting bioeconomy innovation.

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• RISE Research Institutes of Sweden: Swedish applied research institute (including the former Innventia) that operates pilot plants, coating/printing trials, and biocomposite testing for Nordic paper, board, and packaging clients. Functionally interchangeable with KCL for pulp-and-paper scale-up work.
• FPInnovations: Canadian non-profit forest-products research organization that runs pilot facilities, performs laboratory testing, and develops cellulose-based biomaterials for the pulp and paper industry. Same piloting-services-plus-proprietary-IP model as KCL.
• Centre Technique du Papier (CTP): French paper-industry technical center providing pilot coating, printing, converting, and laboratory services to paper and packaging manufacturers. Direct competitor for European pilot and laboratory engagements.
• VTT Technical Research Centre of Finland: Finnish state-owned applied research organization that runs pilot facilities and laboratory services overlapping with KCL's bioeconomy and fiber processing platform. Same geography and customer base; competes for the same R&D and piloting budgets.

Emerging players

• CelluForce: Canadian producer of cellulose nanocrystals (CNC) for advanced materials applications. Direct competing technology to KCL's CNF line, with similar end-markets in packaging, composites, and specialty biomaterials.
• FiberLean Technologies: Manufacturer of microfibrillated cellulose (MFC) additives for paper and packaging — competes directly with KCL MFC/CNF products in the cellulose biomaterials space, though without the open-access piloting service layer.

Broad incumbents

• Borregaard: Norwegian bio-based specialty chemicals company selling lignin, cellulose fibrils (Exilva), and biopolymers into industrial markets including paper, packaging, and biocomposites. Adjacent competitor in bioeconomy raw materials KCL is also developing.
• UPM Biochemicals: Finnish forest industry major that divested biocomposites to KCL and is developing bio-based platform chemicals (glycols, lignin monomers). Both a former owner and a future supplier/customer relationship, and a competitive counterparty in bioeconomy materials development.
• Sappi Biotech: South African-headquartered forest products group that has built in-house pilot and biomaterials development (including MFC and 3D-printing composites) that competes with KCL on a corporate-R&D rather than open-access basis. Former KCL-owner cohort stakeholder on the demand side.
• Fraunhofer Institute for Microstructure of Materials and Systems (IMWS): German applied-research institute that operates pilot lines for fiber-based materials, biocomposites, and barrier coatings. Broader portfolio than KCL but overlaps on bio-based pilot and characterization services for European packaging customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/watch?v=D5HM7TDANn4
• LinkedInlinkedin.com/company/kcl/mycompany/?viewAsMember=true

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KCL